414 a Fitst-In-Human Study of BLZ-100 (Tozuleristide) Demonstrates Tolerability and Fluorescence Contrast in Skin Cancer

Journal of Investigative Dermatology- United Kingdom

doi 10.1016/j.jid.2018.03.421


Related search